2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Engineering the Immune System: Gene and Cell Based Modulation

The field of engineering the immune system through gene and cell-based editing is among the most innovative frontiers in modern medicine. Combining advanced genetic engineering, cellular therapy, and immunology, researchers are discovering new ways to modulate immune responses, strengthen immune defenses against cancer, autoimmune diseases, and infectious diseases.

The key sessions in the (CGTWC) 2026 address CAR-T and TCR design, gene-modified immune cells, and translational science linking discovery with clinical practice.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis